DERMATODUMON
ActiveDERMATODUMON has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €59k and a net result of €6k. Equity is growing by ~12.9% per year across the filed fiscal years. Its solvency ranks better than 36% of 16491 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
76
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability74▼-2
Solvency70=
Growth52=
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €4k at 30 days acceptable
Liquidity short (current ratio 0.77 against 0.64 in 2024; short-term debt: 41.1% and cash: 17% of total assets), and 54.8% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
45.2%
Return on assets
4.4%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-07-2026, 8 days ahead of the deadline.
NBB · 5 filingsDeviation from the deadline
2025
8 d early
2024
31 d early
2023
28 d early
2022
23 d late
2021
3 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
19-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€59k▲ 10.7%
2024 · €53k
2021: €36k
2022: €41k
2023: €46k
2024: €53k
2021 → 2025
Total assets
€130k▲ 11.1%
2024 · €117k
2021: €175k
2022: €171k
2023: €139k
2024: €117k
2021 → 2025
Net result
€6k▼ 14.9%
2024 · €7k
2021: €33k
2022: €4k
2023: €6k
2024: €7k
2021 → 2025
Working capital
€-12k▲ 38.5%
2024 · €-20k
2021: €-85k
2022: €-71k
2023: €-35k
2024: €-20k
2021 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€36k-€41k▲ 11.3%€46k▲ 14.3%€53k▲ 14.3%€59k▲ 10.7%
Operating result€43k-€6k▼ 85.9%€10k▲ 70.2%€10k▲ 1.4%€10k▼ 5.3%
Net result€33k-€4k▼ 87.7%€6k▲ 41.6%€7k▲ 14.3%€6k▼ 14.9%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 5% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €130k
Fixed assets
€89k▲ 9.1%
Current assets
€41k▲ 15.6%
Equity and liabilities €130k
Equity
€59k▲ 10.7%
Debt
€71k▲ 11.4%
The debt ratio rises from 54.6% to 54.8%. Equity and debt are higher.
Key figures and ratios
EBITDA
€26k▲
2024 · €25k
Cash flow
€22k▲
2024 · €21k
Solvency
45.2%▼
2024 · 45.4%
Current ratio
0.77▲
2024 · 0.64
Quick ratio
0.77▲
2024 · 0.64
Debt / equity
1.21▲
2024 · 1.20
ROE
9.6%▼
2024 · 12.5%
ROA
4.4%▼
2024 · 5.7%
Interest coverage
22.12▼
2024 · 23.01
Debt
€71k▲
2024 · €64k
Debt ≤ 1 year
€53k▼
2024 · €56k
Debt > 1 year
€18k▲
2024 · €8k
Income taxes
€3k▲
2024 · €3k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€117k€130k▲
Fixed assets21/28€82k€89k▲
Intangible fixed assets21€81k€68k▼
Tangible fixed assets22/27€380€21k▲
Plant, machinery and equipment23€71€15k▲
Furniture and vehicles24€308-
Other tangible fixed assets26-€5k
Current assets29/58€35k€41k▲
Amounts receivable within one year40/41€2k€60▼
Trade receivables40€2k-
Other amounts receivable41-€60
Cash at bank and in hand54/58€15k€22k▲
Deferred charges and accrued income490/1€19k€19k▲
Equity and liabilities
Total equity and liabilities10/49€117k€130k▲
Equity10/15€53k€59k▲
Contributions10/11€3k€3k=
Profit (loss) carried forward14€50k€56k▲
Amounts payable17/49€64k€71k▲
Amounts payable after more than one year17€8k€18k▲
Financial debts170/4€8k€18k▲
Amounts payable within one year42/48€56k€53k▼
Current portion of amounts payable after more than one year42€6k€9k▲
Trade debts44€1k€2k▲
Suppliers440/4€1k€2k▲
Taxes, remuneration and social security45€73-
Taxes450/3€73-
Other amounts payable47/48€48k€42k▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€15k€16k▲
Other operating charges640/8€707€623▼
Gross operating margin9900€26k€26k▲
Operating profit (loss)9901€10k€10k▼
Financial income75/76B€0€0=
Recurring financial income75€0€0=
Financial charges65/66B€1k€1k▲
Recurring financial charges65€1k€1k▲
Profit (loss) for the period before taxes9903€9k€9k▼
Income taxes67/77€3k€3k▲
Profit (loss) for the period9904€7k€6k▼
Profit (loss) for the period to be appropriated9905€7k€6k▼
Appropriation of the result
Profit (loss) to be appropriated9906€50k€56k▲
Profit (loss) brought forward from the previous period14P€43k€50k▲
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
23-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
30-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
03-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
23-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 23 days late
2022
31-12
Financial
Weakest financial yearnet €4k ▼87.7%
Net result drops to €4k, the lowest in the series; recovery starts the following year.
03-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 3 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Wezembeek-Oppem · 1 establishment unit since 2021
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Hertogweg 361970 Wezembeek-OppemGround area
1,168 m²
Building footprint
128 m²
Volume, LiDAR
455 m³
Parcel 22302C0097/00G000, Flanders · tallest building 7.4 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
DERMATODUMON
since 20212.319.594.454
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 22302C0097/00G000 | Flanders | 1,168 m² | 1 · 127 m² | 7.4 m · 1 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dr Eline De Keyser Dermatoloog
BE 0775.987.825
Gent · Eq €59k
NeuVi Anesthésie
BE 1001.839.259
Liège · Eq €59k
Hypnos - Cabinet Médical
BE 0715.684.509
Sint-Lambrechts-Woluwe · Eq €59k
Dr. C. Kesteloot
BE 0722.595.065
Grimbergen · Eq €59k
DR. LEEN VAN CROMBRUGGE
BE 1004.049.572
Wuustwezel · Eq €59k
Of 16,627 companies in sector 86220 we hold annual accounts for 7,973. 5,364 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded31-03-2021
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
86109Human health activities
Sources
Crossroads Bank for EnterprisesNational Bank · 5 filingsAddress and cadastre registers
Data from official sources, last processed on 17-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryE-mail:daphnee.dumon@dermatodumon.be